During three weekends in September and October, 24 participants of a citizen panel on making choices in health care (burgerforum ‘keuzes in de zorg’) debated about the coverage of medical treatments in the basic benefit package in The Netherlands, including the underlying values and principles they find important.
This included questions as to whether society as a whole should pay for gastric bypass for overweight people, or for cosmetic dental care. The citizen council will lead to a pamphlet, which will be discussed in a conference with policy makers and stakeholders in the beginning of 2018.
The citizen panel on making choices in health care (burgerforum ‘keuzes in de zorg’) was initiated by the section HTA of the Department for Health Evidence. Project leader is Rob Baltussen (theme Infectious diseases and global health).
For more information, see the latest newsletter and website
Related news items
Large AI project receives over €95 million for ten years of public-private research23 September 2021
Radboud university medical center (Radboudumc) participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboud university medical center leads five of these eight labs.read more
Reading ADP-ribosylation signaling using chemical biology and interaction proteomics published in Molecular Cell22 September 2021
Kasia Kliza and Michiel Vermeulen worked on a project to synthesize biotinylated ADPr-based probes that can identify ADPr readers and determine their specificity for mono- and polyADPr. They published this in Molecular Cell.read more
Systematic analysis of short tandem repeats in 38,095 exomes provides an additional diagnostic yield22 September 2021
Christian Gilissen and colleagues published in Genetics in Medicine about their work guiding the application of short tandem repeat analysis in clinical exome sequencing.read more
New start-up Patholyt will bring AI research into pathology diagnostics21 September 2021
Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.read more